A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer
Open Access
- 1 October 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (10) , 1267-1272
- https://doi.org/10.1023/a:1008364018881
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Phase I trial of gemcitabine (Gemzar®), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancerAnti-Cancer Drugs, 1999
- Current chemotherapeutic possibilities in pancreaticobiliary cancerAnnals of Oncology, 1999
- A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)British Journal of Cancer, 1999
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Assessing clinical benefit in the treatment of pancreas cancer: Gemcitabine compared to 5-fluorouracilEuropean Journal Of Cancer, 1997
- A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerAnnals of Oncology, 1996
- Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreasInvestigational New Drugs, 1994
- A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinomaCancer, 1991
- Continuous 5-Fluorouracil (5FU) Infusion in Carcinoma of the Pancreas: A Phase II StudyThe Lancet Healthy Longevity, 1988
- A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric CarcinomaJAMA, 1985